This Biomedical Company Announces Major Tick-Borne Disease Study

60 Degrees Pharma Moves Forward with Tafenoquine Study for Tick-Borne Disease, Babesiosis.

Please note: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

60 Degrees Pharmaceuticals (60P), a bio-pharmaceutical company committed to developing innovative solutions for neglected and under-treated diseases, recently announced its Institutional Review Board (IRB) ap…